Substance Use Disorders (Treatment)

Psychosocial Treatments Part 1

100

True or false: psychosocial treatments for substance use disorders are equally efficacious

True

200

A technique used to promote sobriety by finding triggers/stressors for substance use and avoiding those situations

Relapse provention

300

A therapeutic approach aimed at helping individuals identify and resolve ambivalence regarding alcohol and other drug use

Motivational Enhancement Therapy (MET), ie Motivational Interviewing

400

Average member sobriety in AA is ___ years (closest answer wins)

10

500

At __ AA meetings, non-alcoholics are welcome

Open

Psychosocial Treatments Part 2

100

The first 12-step program

AA

200

True or false: motivational enhancement therapy (MET) and cognitive behavioral therapy (CBT) are more effective than 12 step programs

False, 12-step programs are slightly more effective at promoting continued abstinence/sobriety

300

This psychotherapist may have inspired a patient to start AA around 1935

Carl Jung

400

Operant conditioning technique used to promote continued abstinence, by providing small rewards/reinforcers

Contingency management

500

As of 2018, ___ number of weekly NA meetings occur in 144 countries (closest answer wins)

70,000

Medications Part 1

100

___ is a μ opioid receptor full agonist

Methadone

200

FDA approved medication for Gambling Disorder

None

But dopamine agonists, naltrexone, lithium, antidepressants, and antipsychotics have been used

300

___% of VA patients receive medication treatment for alcohol use disorder (closest answer wins)

7-11%

400

___ is a μ opioid receptor partial agonist

Buprenorphine

500

Suboxone has ___% bioavailability (closest answer wins)

30%

Medications Part 2

100

Induced hangover-like effects by inhibiting the enzyme aldehyde dehydrogenase

Disulfiram (bonus: what line treatment is it?)

200

Receptor target for treatment of T2DM, obesity, and potentially addiction through hypothesized mediation of dopamine pathways.

GLP-1 receptor (medications are receptor agonists)

300

FDA approved medication for stimulant use disorder

None

400

___ is a μ opioid receptor antagonist

Naltrexone

500

Hepatically safe medication for AUD and theorized MOA

Acamprosate

NMDA receptor antagonist and positive allosteric modulator of GABA-A receptors.

Comorbidities/Health consequences

100

Animal sedative being increasingly abused and mixed with fentanyl

Xylazine (tranq)

Bonus question: what medication is it similar to?

200

Leading global cause of preventable death

Tobacco use

300

What percentage of drug overdose deaths in the US in 2021 are associated with opioids? (closest answer wins)

75%

400

Under conditions for further study in DSM-5: in utero exposure to what substance?

Alcohol

(Neurobehavioral disorder associated with prenatal alcohol exposure)

500

From 1999 to 2021, drug related deaths have increased by what percentage? (closest answer wins)

780%